SEOM-GECOD clinical guideline for cancer of unknown primary (update 2025)


Por: Losa, F, Etxaniz, O, Giménez, A, Gomila, P, Iglesias, L, Longo, F, Nogales, E, Sánchez, A, Soler, G and Fernández, I

Publicada: 1 may 2026 Ahead of Print: 1 mar 2026
Resumen:
Cancer of unknown primary (CUP) is defined as a heterogeneous group of tumors that appear as metastases for which a standard diagnostic work-up fails to identify the tissue of origin. There is now high-level evidence showing that actionable genomic alterations should be routinely determined in patients with CUP to enable molecularly guided therapy as appropriate. In this guideline (updated in 2025), we summarize diagnostic processes and therapeutic options for CUP, as well as new developments in molecular medicine that will help to improve the poor outcomes associated with this unique disease entity.

Filiaciones:
Losa, F:
 ICO Hospitalet, Hosp St Joan Despi Moises Broggi, Barcelona, Spain

:
 Hosp Germans Trias i Pujol, ICO Badalona, Barcelona, Spain

Giménez, A:
 Hosp Lluis Alcanys Xativa, Valencia, Spain

Gomila, P:
 Hosp Miguel Servet Zaragoza, Zaragoza, Spain

Iglesias, L:
 Hosp Univ 12 Octubre, Madrid, Spain

Longo, F:
 Hosp Univ Ramon y Cajal, IRYCIS, CIBERONC, Madrid, Spain

Nogales, E:
 Hosp Univ Virgen Macarena, Seville, Spain

Sánchez, A:
 Hosp Univ Puerta Hierro, Majadahonda, Madrid, Spain

Soler, G:
 Hosp Germans Trias i Pujol, Hosp Mataro, ICO Badalona, Barcelona, Spain

Fernández, I:
 Hosp Alvaro Cunqueiro, IIGS, Vigo, Spain
ISSN: 1699048X





CLINICAL & TRANSLATIONAL ONCOLOGY
Editorial
Springer-Verlag Italia, GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND, Estados Unidos America
Tipo de documento: Article
Volumen: 28 Número: 5
Páginas: 1610-1623
WOS Id: 001711263200001
ID de PubMed: 41806238
imagen Green Submitted, hybrid

MÉTRICAS